Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Sullivan

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The American Journal of Clinical Nutrition|May 10, 2019
Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trialAnoja W Gunaratne, Maria Makrides, Carmel T Collins, et al.
Plos One|June 13, 2020
Micronutrient intake and prevalence of micronutrient inadequacy among women (15-49 y) and children (6-59 mo) in South Kivu and Kongo Central, Democratic Republic of the Congo (DRC)Najma A Moumin, Moira Donahue Angel, Crystal D Karakochuk, et al.
BMJ Open|March 20, 2015
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trialCarmel T Collins, Robert A Gibson, Peter J Anderson, et al.
BMJ Open|February 17, 2024
Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinicsBing Wang, Prabha Andraweera, Margaret Danchin, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
The Journal of Infectious Diseases|September 6, 2021
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidisMark McMillan, Ann P Koehler, Andrew Lawrence, et al.
Journal of Public Health (Oxford, England)|August 12, 2025
Nudging towards COVID-19 and influenza vaccination in children with medically at-risk conditionsBing Wang, Prabha Andraweera, Margie Danchin, et al.
BMJ Open|May 6, 2021
Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
Vaccine|July 10, 2025
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in AustraliaPrabha H Andraweera, Bing Wang, Margie Danchin, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The American Journal of Clinical Nutrition|May 10, 2019
Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trialAnoja W Gunaratne, Maria Makrides, Carmel T Collins, et al.
Plos One|June 13, 2020
Micronutrient intake and prevalence of micronutrient inadequacy among women (15-49 y) and children (6-59 mo) in South Kivu and Kongo Central, Democratic Republic of the Congo (DRC)Najma A Moumin, Moira Donahue Angel, Crystal D Karakochuk, et al.
BMJ Open|March 20, 2015
Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trialCarmel T Collins, Robert A Gibson, Peter J Anderson, et al.
BMJ Open|February 17, 2024
Nudging towards COVID-19 and influenza vaccination uptake in medically at-risk children: EPIC study protocol of randomised controlled trials in Australian paediatric outpatient clinicsBing Wang, Prabha Andraweera, Margaret Danchin, et al.
The New England Journal of Medicine|October 27, 2022
Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 YearsJacqueline F Gould, Maria Makrides, Robert A Gibson, et al.
JAMA Network Open|June 9, 2023
Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born PretermThomas R Sullivan, Jacqueline F Gould, Jana M Bednarz, et al.
The Journal of Infectious Diseases|September 6, 2021
B Part of It School Leaver Study: A Repeat Cross-Sectional Study to Assess the Impact of Increasing Coverage With Meningococcal B (4CMenB) Vaccine on Carriage of Neisseria meningitidisMark McMillan, Ann P Koehler, Andrew Lawrence, et al.
Journal of Public Health (Oxford, England)|August 12, 2025
Nudging towards COVID-19 and influenza vaccination in children with medically at-risk conditionsBing Wang, Prabha Andraweera, Margie Danchin, et al.
BMJ Open|May 6, 2021
Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trialJacqueline F Gould, Rachel M Roberts, Peter J Anderson, et al.
Vaccine|July 10, 2025
Randomised controlled trials of behavioural nudges delivered through text messages to increase influenza and COVID-19 vaccine uptake among pregnant women (EPIC study) in AustraliaPrabha H Andraweera, Bing Wang, Margie Danchin, et al.
Pageof 10